gastric juice protein is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-02-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
Identity and purity are checked with standard peptide techniques. Reversed-phase high-performance liquid chromatography separates the main peak from closely related impurities and yields a percentage purity. Mass spectrometry confirms that the measured mass matches the theoretical value. Amino acid analysis offers an independent check on overall composition. These analytical methods characterize the material itself and reveal nothing about how it behaves in a living system.
In its common research form the peptide is supplied as a lyophilized powder. It dissolves readily in water and in typical aqueous buffers, which simplifies preparation of working solutions. Laboratories usually prepare small aliquots instead of one large volume. The dry material appears as a white to off-white solid with no distinctive odor. Bulk quantities are typically shipped in sealed vials.
Lyophilized material is generally kept cold, commonly at minus twenty degrees Celsius, and shielded from moisture and light. Solutions are less stable than the dry powder, so repeated freeze-thaw cycles are avoided by splitting the material into single-use portions. Published stability data for this particular peptide are limited, which means suggested hold times should be read as provisional. Long-term refrigeration of reconstituted solutions is not well supported by available evidence.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic pentadecapeptide | Composed of fifteen amino acid residues |
| Amino acid sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | Single-letter form GEPPPGKPADDAGLV |
| Original source | Fragment of a protein in human gastric juice | First characterized in the 1990s |
| Number in name | 157 | Refers to the fragment's position in the source protein |
| Human trial evidence | Limited | Preclinical rodent data predominate |
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
Wanted immunogenicity typically relates to vaccines, where the injection of an antigen (the vaccine) provokes an immune response against the pathogen, protecting the organism from future exposure. Immunogenicity is a central aspect of vaccine development. Unwanted immunogenicity is an immune response by an organism against a therapeutic antigen. This reaction leads to production of anti-drug-antibodies (ADAs), inactivating the therapeutic effects of the treatment and potentially inducing adverse effects. A challenge in biotherapy is predicting the immunogenic potential of novel protein therapeutics. For example, immunogenicity data from high-income countries are not always transferable to low-income and middle-income countries. Another challenge is considering how the immunogenicity of vaccines changes with age. Therefore, as stated by the World Health Organization, immunogenicity should be investigated in a target population since animal testing and in vitro models cannot precisely predict immune response in humans. Antigenicity is the capacity of a chemical structure (either an antigen or hapten) to bind specifically with a group of certain products that have adaptive immunity: T cell receptors or antibodies (a.k.a. B cell receptors). Antigenicity was more commonly used in the past to refer to what is now known as immunogenicity, and the two terms are still often used interchangeably. However, strictly speaking, immunogenicity refers to the ability of an antigen to induce an adaptive immune response.
== History == The areas later known as the Sudetenland never formed a single historical region, which makes it difficult to distinguish the history of the Sudetenland separately from that of Bohemia until the advent of nationalism in the 19th century.
=== Safety === Tests of common teas have detected residues of banned toxic pesticides. Additionally, tests have indicated contamination of heavy metals and toxic elements in some brewed teas, some having a proportional relationship between the concentration of contaminants and steeping time. Another study indicated that heavy metals in commercial teas are tightly bound to tea leaves, with a minor amount leeching off into the water while brewing.
In June 1976, scientists from the Scripps Institution of Oceanography obtained the first evidence for submarine hydrothermal vents along the Galápagos Rift, a spur of the East Pacific Rise, on the Pleiades II expedition, using the Deep-Tow seafloor imaging system. In 1977, the first scientific papers on hydrothermal vents were published by scientists from the Scripps Institution of Oceanography; research scientist Peter Lonsdale published photographs taken from deep-towed cameras, and PhD student Kathleen Crane published maps and temperature anomaly data. Transponders were deployed at the site, which was nicknamed "Clam-bake", to enable an expedition to return the following year for direct observations with the DSV Alvin. Chemosynthetic ecosystems surrounding the Galápagos Rift submarine hydrothermal vents were first directly observed in 1977, when a group of marine geologists funded by the National Science Foundation returned to the Clambake sites. The principal investigator for the submersible study was Jack Corliss of Oregon State University. Corliss and Tjeerd van Andel from Stanford University observed and sampled the vents and their ecosystem on February 17, 1977, while diving in the DSV Alvin, a research submersible operated by the Woods Hole Oceanographic Institution (WHOI). Other scientists on the research cruise included Richard (Dick) Von Herzen and Robert Ballard of WHOI, Jack Dymond and Louis Gordon of Oregon State University, John Edmond and Tanya Atwater of the Massachusetts Institute of Technology, Dave Williams of the U.S.
HRBeauty LLC, d.b.a. rhode (stylized in all lowercase), is an American skincare brand founded by model and entrepreneur Hailey Bieber, alongside Michael D. and Lauren Ratner, in 2022. It is based in Beverly Hills, California. Rhode products are distributed through its official website, Sephora, and available in multiple regions, including the United States, Canada, the United Kingdom, and Australia. Originally launched offering three products, Rhode's product line has since grown to include facial cleansers, lotions, lip balms and blushes. It was acquired by e.l.f. Beauty in May 2025 in a US$1 billion deal.
Sources: en.wikipedia.org
Mahathir's heavy-industrialisation programme also included Perwaja Steel, established in 1982 as a government-backed project to develop a domestic steel industry. The company subsequently accumulated substantial losses despite continued government support; a 2024 study in the Malaysian Journal of Economic Studies reported accumulated losses of RM9.9 billion between 1982 and its privatisation in 1996, rising to RM15 billion by the time operations ceased in 1999. Mahathir later described Perwaja as a miscalculation on his part while defending the broader record of his industrial policies. On the economic front, Mahathir inherited the New Economic Policy from his predecessors, which was designed to improve the economic position of the bumiputera—Malaysia's Malays and Indigenous peoples—via targets and affirmative action in areas such as corporate ownership and university admission. Like many of his economic liberal contemporaries such as British prime minister Margaret Thatcher, Mahathir actively pursued privatisation of government enterprises from the early 1980s. Mahathir believed this would provide economic opportunities for bumiputera and their businesses. His government privatised airlines, utilities and telecommunication firms, accelerating to a rate of about 50 privatisations a year by the mid-1990s. Privatisation generally improved the working conditions of Malaysians in privatised industries and raised significant revenue for the government.
== Uses == Fritillaria extracts are used in traditional Chinese medicine under the name chuan bei mu, and in Latin, bulbus fritillariae cirrhosae. The bulbs of Fritillaria roylei have been used as antipyretics and expectorants. Lilium bulbs, particularly Lanzhou lily (Lilium davidii) are used as food in China and other parts of Asia. Calochortus bulbs were eaten by Native Americans and as a famine food by Mormon settlers. During World War II, starvation conditions in the Netherlands (Hongerwinter, hunger winter 1944) led to Tulipa bulbs being used as food. Other members of the family used for food include Clintonia (leaves), Medeola (roots), Erythronium (corms), and Fritillaria (bulbs).
Timothy C. Bates (born 1963) is a professor of differential psychology at the University of Edinburgh. His research interests include the genetics of reading and spelling, intelligence, and personality.
1993/2452) Restrictive Trade Practices (Standards and Arrangements) (Services) Order 1993 (S.I. 1993/2453) Sole (Specified Sea Areas) (Prohibition of Fishing) Order 1993 (S.I. 1993/2459) East Gloucestershire National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/2460) Mulberry National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/2461) Southampton Community Health Services National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/2462) London South Circular Trunk Road (A205)(London Road, Lewisham and Southwark) (Box Junction) Order 1993 (S.I. 1993/2463) London South Circular Trunk Road (A205) (Lordship Lane, Lewisham and Southwark) (Box Junction) Order 1993 (S.I. 1993/2464) Sole (Specified Sea Areas) (Prohibition of Fishing) (No. 2) Order 1993 (S.I. 1993/2465) Restrictive Trade Practices (Standards and Arrangements) (Goods) Order 1993 (S.I. 1993/2473) Road Traffic Accidents (Payments for Treatment) Order 1993 (S.I. 1993/2474) Income Tax (Interest Relief) (Qualifying Lenders) (No. 3) Order 1993 (S.I. 1993/2478) Offshore Installations (Safety Zones) (No. 4) Order 1993 (S.I. 1993/2479) Miscellaneous Factories (Transitional Provisions) Regulations 1993 (S.I. 1993/2482) Design Right (Semiconductor Topographies) (Amendment) Regulations 1993 (S.I. 1993/2497) Value Added Tax (Beverages) Order 1993 (S.I. 1993/2498) Smoke Control Areas (Authorised Fuels) (Amendment) Regulations 1993 (S.I. 1993/2499)
Sources: en.wikipedia.org
It is a chain of fifteen amino acids, referred to as a pentadecapeptide. The sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It corresponds to a fragment of a protein found in human gastric juice.
It is neither a naturally circulating hormone nor an approved medicine in most countries. It is a synthetic peptide fragment used chiefly as a laboratory research material. Its regulatory status varies by jurisdiction, and it is not authorized as a therapeutic product in the United States or the European Union.
Published human evidence is very limited. Most findings come from rodent studies conducted by a small number of groups. As a result, statements about its effects in humans are generally described as uncertain rather than established.
Dry powder is commonly held at minus twenty degrees Celsius, desiccated and away from light. Cold storage slows degradation of the lyophilized material.